DaVita Inc. (DVA)
| Market Cap | 8.29B |
| Revenue (ttm) | 13.32B |
| Net Income (ttm) | 771.92M |
| Shares Out | 70.60M |
| EPS (ttm) | 9.76 |
| PE Ratio | 12.02 |
| Forward PE | 9.53 |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 620,038 |
| Open | 117.54 |
| Previous Close | 117.28 |
| Day's Range | 117.16 - 118.72 |
| 52-Week Range | 113.97 - 179.60 |
| Beta | 0.99 |
| Analysts | Hold |
| Price Target | 145.00 (+23.52%) |
| Earnings Date | Oct 29, 2025 |
About DVA
DaVita Inc. provides kidney dialysis services for patients suffering from chronic kidney failure in the United States. The company operates kidney dialysis centers and provides related lab services in outpatient dialysis centers. It also offers outpatient, hospital inpatient, and home-based hemodialysis services; operates clinical laboratories that provide routine laboratory tests for dialysis and other physician-prescribed laboratory tests for ESRD patients; and management and administrative services to outpatient dialysis centers. In addition... [Read more]
Financial Performance
In 2024, DaVita's revenue was $12.82 billion, an increase of 5.56% compared to the previous year's $12.14 billion. Earnings were $936.34 million, an increase of 35.40%.
Financial StatementsAnalyst Forecast
According to 4 analysts, the average rating for DVA stock is "Hold." The 12-month stock price target is $145.0, which is an increase of 23.52% from the latest price.
News
DaVita: More Volatile But Better Upside Than Fresenius
DaVita (DVA) is rated a speculative 'Buy,' reflecting undervaluation despite recent earnings volatility. DVA's moat stems from its dominant US dialysis clinic network, but its reliance on Medicare rei...
DaVita Inc. (DVA) Presents at 7th Annual Wolfe Research Healthcare Conference Transcript
DaVita Inc. ( DVA) 7th Annual Wolfe Research Healthcare Conference November 17, 2025 11:20 AM EST Company Participants Joel Ackerman - CFO & Treasurer Conference Call Participants Justin Lake - Wolfe...
DaVita Inc. to Participate in Fireside Chat with Wolfe Research
DENVER , Nov. 14, 2025 /PRNewswire/ -- DaVita Inc. (NYSE: DVA) today announced that its chief financial officer, Joel Ackerman, will participate in a fireside chat at the Wolfe Research Healthcare Con...
DaVita Marks 25 Years of Innovation with Breakthrough Kidney Care Research at ASN Kidney Week 2025
Six new studies from DaVita Clinical Research spotlight improved outcomes with GLP-1 use, advancements in treatments, transplant access and end-of-life care DENVER and HOUSTON , Nov. 4, 2025 /PRNewsw...
DaVita Inc. (DVA) Q3 2025 Earnings Call Transcript
DaVita Inc. ( DVA) Q3 2025 Earnings Call October 29, 2025 5:00 PM EDT Company Participants Nic Eliason - Group Vice President of Investor Relations Javier Rodriguez - CEO & Executive Director Joel Ac...
DaVita misses quarterly profit estimates on rising costs, lower volumes
DaVita missed Wall Street estimates for third-quarter profit on Wednesday, as the kidney dialysis provider grappled with rising patient care costs and declining treatment volumes.
DaVita Inc. 3rd Quarter 2025 Results
DENVER , Oct. 29, 2025 /PRNewswire/ -- DaVita Inc. (NYSE: DVA) announced financial and operating results for the quarter ended September 30, 2025. "Our third quarter performance was in line with our e...
3 Healthcare Stocks That Are Screaming Deals Right Now
DaVita's recession-resistant business is growing internationally, but shares continue to trade at a heavily discounted valuation. Merck could be in for a major move if the pharma can soften the blow o...
DaVita Leads the Way in Evaluating Middle Molecule Clearance with Two New Initiatives
New U.S. data will offer first-of-its-kind evidence in patients with kidney failure DENVER , Oct. 20, 2025 /PRNewswire/ -- DaVita today announced the launch of two groundbreaking initiatives aimed to...
DaVita Inc. Schedules 3rd Quarter 2025 Investor Conference Call
DENVER , Oct. 13, 2025 /PRNewswire/ -- DaVita Inc. (NYSE: DVA), announced today that it will hold its quarterly conference call to discuss third quarter results on Wednesday, October 29, 2025, at 5:00...
DaVita Honors 25 Years of Clinical Advancement in Chronic Disease Care
Largest kidney care research arm advances science to inform care delivery DENVER , Aug. 27, 2025 /PRNewswire/ -- As part of its 25th-anniversary celebration, DaVita, a leading provider of comprehensiv...
Ransomware attack at dialysis firm DaVita affects 2.7 million people, US health dept website shows
A ransomware attack that encrypted certain elements of dialysis firm DaVita's network affected 2.7 million people, the U.S. health department's website showed on Thursday.
DaVita: Aggressive Buybacks Despite Rising Cost Of Debt
DaVita has reduced the share count by over 10% in the last six months, but interest expenses increased by 50% Y/Y. International revenues grew by 36% Y/Y, and DaVita is pending regulatory approval to ...
DaVita Inc. (DVA) Q2 2025 Earnings Call Transcript
DaVita Inc. (NYSE:DVA) Q2 2025 Earnings Conference Call August 5, 2025 5:00 PM ET Company Participants Javier J. Rodriguez - CEO & Executive Director Joel Ackerman - CFO & Treasurer Nic Eliason - Gro...
DaVita beats quarterly profit on steady demand for dialysis services
DaVita beat Wall Street estimates for second-quarter profit on Tuesday, driven by demand for its kidney dialysis services.
DaVita Inc. 2nd Quarter 2025 Results
DENVER , Aug. 5, 2025 /PRNewswire/ -- DaVita Inc. (NYSE: DVA) announced financial and operating results for the quarter ended June 30, 2025. "We're reporting another solid quarter, fueled by our unwav...
DaVita Inc. Schedules 2nd Quarter 2025 Investor Conference Call
DENVER , July 17, 2025 /PRNewswire/ -- DaVita Inc. (NYSE: DVA), announced today that it will hold its quarterly conference call to discuss second quarter results on Tuesday, August 5, 2025, at 5:00 p....
20 stocks primed for rapid growth while trading at half of Nvidia's valuation
When selecting investments, it is easy to get hung up on a particular metric, such as a dividend yield or a price ratio, but investors need to look deeper or they might miss opportunities.
DaVita Statement on Government's Kidney Care Choices (KCC) Model Updates
DENVER , May 30, 2025 /PRNewswire/ -- DaVita, a comprehensive kidney care company, issued the following statement in response to updates this week from the Center for Medicare and Medicaid Innovation ...
DaVita: International Expansion And Buybacks Will Boost Returns
International expansion continues with new clinics in Brazil, Ecuador, Chile, and Colombia, supporting long-term growth beyond the US market. DaVita's stock offers a 10% FCF yield, and the share count...
DaVita Inc. Announces Upsize and Pricing of $1 Billion Senior Notes Offering
DENVER , May 20, 2025 /PRNewswire/ -- DaVita Inc. (NYSE: DVA) ("DaVita") announced today the upsize and pricing of its previously announced private offering (the "offering") of its 6.750% senior notes...
DaVita Releases Annual Community Care Report, Highlights Achievements in Corporate Citizenship
Captures key initiatives achieved in 2024, driving 2025 ESG goals DENVER , May 20, 2025 /PRNewswire/ -- Today, DaVita (NYSE: DVA) published its Community Care report, underpinning its long-standing co...
DaVita Inc. Announces Offering of $750 Million Senior Notes
DENVER , May 20, 2025 /PRNewswire/ -- DaVita Inc. (NYSE: DVA) ("DaVita") announced today that it has commenced a private offering (the "offering") of $750 million aggregate principal amount of its sen...
DaVita Inc. (DVA) Q1 2025 Earnings Call Transcript
DaVita Inc. (NYSE:DVA) Q1 2025 Earnings Conference Call May 12, 2025 5:00 PM ET Company Participants Nic Eliason - Group VP, IR Javier Rodriguez - CEO Joel Ackerman - CFO Conference Call Participants...
DaVita beats quarterly profit estimates amid stable demand for dialysis services
DaVita beat Wall Street estimates for first-quarter profit on Monday, driven by steady demand for its kidney dialysis services.